Science Explorer Back to mapMap
Discussion
Company · Wilmington · United States

CuriRx (United States)

curirx.comROR OpenAlex
Research works
3
▼ 47% vs 2018-21
Citations
387
129.4 per fractional work
Top-10% rate
32.0%
all institutions 10.0%
Open access
24%
world 40%
International
8%
world 18%
CuriRx (United States)

Not ranked overall: CuriRx (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CuriRx (United States) work in?

In all years, 73% of research at CuriRx (United States) is in Life Sciences, 20% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (27%), Agricultural and Biological Sciences (20%), Immunology and Microbiology (20%). It does 1.5× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 73.3% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 26.7% of its workAgricultural and Biological Sciences: 1 fractional works · 20.0% of its workImmunology and Microbiology: 1 fractional works · 20.0% of its workNeuroscience: 0 fractional works · 6.7% of its workPhysical Sciences: 1 fractional works · 20.0% of its workChemistry: 0 fractional works · 10.0% of its workEngineering: 0 fractional works · 10.0% of its workHealth Sciences: 0 fractional works · 6.7% of its workMedicine: 0 fractional works · 6.7% of its workALL ITS WORKCuriRx (UnitedStates)3fractional works, all years
Life Sciences73%Physical Sciences20%Health Sciences7%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology126.7%
    2. Agricultural and Biological Sciences120.0%
    3. Immunology and Microbiology120.0%
    4. Neuroscience06.7%
    1. Chemistry010.0%
    2. Engineering010.0%
    1. Medicine06.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from CuriRx (United States)?

The most cited paper from CuriRx (United States) is "An immunogenic personal neoantigen vaccine for patients with melanoma" (Patrick Alexander Ott et al., 2017), with 3,022 citations. Next come "Hardening and tanning of insect ootheca, egg cases, egg sac, chorion, and silk" (31) and "Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration" (16).

Most cited papers
#PaperReleasedCitations
1 An immunogenic personal neoantigen vaccine for patients with melanoma Patrick Alexander Ott et al. · Nature Open access 4 Jul 2017 3,022
2 Hardening and tanning of insect ootheca, egg cases, egg sac, chorion, and silk Kaliappanadar Nellaiappan, Manickam Sugumaran · Advances in insect physiology Book chapter 2022 31
3 Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration Vaneet Kumar Sharma, Bijay Misra, Kevin T. McManus et al. · Antibodies Open access 29 Jul 2020 16
4 Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution Indu Javeri, Kaliappanadar Nellaiappan, Charles McNemar et al. · Pharmaceutical Research 26 Jun 2018 4
5 Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics Sanjay Ram, Davinder S. Gill, Peter A. Rice · Current Opinion in Infectious Diseases 28 Nov 2025 1
All 7 most cited papers, with filters and sorting

Which research topics does CuriRx (United States) publish most on?

By volume in 2022-now: Microbial infections and disease research, Reproductive tract infections research, Insect and Arachnid Ecology and Behavior and Bacterial Infections and Vaccines.

Microbial infections and disease research: 0 fractional worksReproductive tract infections research: 0 fractional worksInsect and Arachnid Ecology and Behavior: 0 fractional worksBacterial Infections and Vaccines: 0 fractional worksInsect Utilization and Effects: 0 fractional worksNeurobiology and Insect Physiology Research: 0 fractional works
MicrobiologyGeneticsInsect ScienceCellular and Molecular Neuroscience

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Microbial infections and disease research Microbiology 0 works
  2. 2 Reproductive tract infections research Microbiology 0 works
  3. 3 Insect and Arachnid Ecology and Behavior Genetics 0 works
  4. 4 Bacterial Infections and Vaccines Microbiology 0 works
  5. 5 Insect Utilization and Effects Insect Science 0 works
  6. 6 Neurobiology and Insect Physiology Research Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.2%not open75.8%

World: 40% of research is openly available.

with international co-authors7.7%domestic only92.3%

World: 18% is written across borders.

How has CuriRx (United States)'s research output changed?

Output in 2022-2025 was 47% lower than in 2018-2021.

still counting20202025

Other research institutions in Wilmington

All research institutions in Wilmington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CuriRx (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.